文献速递肺外科

瑞典囊性纤维化肺移植后生存分析

Survival after lung transplantation for cystic fibrosis in Sweden.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

该研究回顾瑞典1991至2014年106例囊性纤维化患者的115次肺移植,总体1年、5年、10年生存率分别为86.4%、73.7%、62.4%。术前感染脓肿分枝杆菌或洋葱伯克霍尔德菌复合群者平均生存8.8年,仍可接受移植。

要点

  • 囊性纤维化肺移植后10年生存率达62.4%。
  • 术前脓肿分枝杆菌或洋葱伯克霍尔德菌感染并非绝对禁忌。
  • 等待期死亡占 listed 患者的14%。

核心结论

  • 瑞典囊性纤维化肺移植后生存良好,与国际数据相当,术前特定耐药菌感染患者也可获得可接受的生存。

主要发现

  • 总体1年生存率86.4%,5年73.7%,10年62.4%;平均生存13.1年(95%CI 11-15.3),中位生存14.6年(95%CI 9.3-19.8)。
  • 性别或移植中心间生存无显著差异;术后3个月内血管和感染并发症导致8例死亡。
  • 术前感染脓肿分枝杆菌或洋葱伯克霍尔德菌复合群的14例患者平均生存8.8年(95%CI 6.1-11.6),无此感染患者为13.2年(95%CI 10.9-15.8)。
  • 19例(占listed患者的14%)在等待期死亡,中位等待时间94天(范围4天至2.5年)。

临床怎么用

  • 对于囊性纤维化终末期患者,肺移植可带来良好长期生存,术前特定耐药菌感染不应作为绝对排除标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In Sweden, lung transplantation has been performed in patients with end-stage lung disease since 1990. We assessed survival after lung transplantation for cystic fibrosis (CF) with focus on early mortality and outcome for patients infected with certain multiresistant bacteria, considered a relative contraindication for lung transplantation. METHODS: Review of CF and transplant databases and patient charts. The Kaplan-Meier method and log-rank test were used for survival analysis and group comparison. RESULTS: From November 1991 to December 2014, 115 transplantations were performed in 106 CF patients (9 retransplantations): 3 heart-lung, 106 double lung-, 1 double lobar- and 5 single lung transplantations, constituting 13% (115/909) of all lung-transplant procedures performed in Sweden. The mean age at surgery was 31 (SD 10, range 10-61) years and there were 48% females. Overall 1-year survival after lung transplantation for CF was 86.4%, 5-year survival was 73.7% and 10-year survival was 62.4%. The mean and median survival after transplantation were 13.1 (95% confidence interval (CI): 11-15.3) and 14.6 (95% CI: 9.3-19.8) years, respectively, and there was no significant difference for gender or transplant centre. Extracorporeal membrane oxygenation was used as a bridge to transplantation in 11 cases and five patients received reconditioned lungs. Vascular and infectious complications contributed to eight deaths within the first three postoperative months. The mean survival for 14 patients infected pretransplant with Mycobacterium abscessus or Burkholderia cepacia complex was 8.8 (95% CI: 6.1-11.6) years compared to 13.2 (95% CI: 10.9-15.8) years for patients negative for these bacteria. Nineteen patients (14% of all listed), of whom three were listed for retransplantation, died while waiting a median time of 94 days (range 4 days-2.5 years) after listing. CONCLUSIONS: Survival after lung transplantation in Sweden is good, also for patients with pretransplant infection with M. abscessus or B. cepacia complex, and comparable to international data.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gilljam M, Nyström U, Dellgren G, et al. Survival after lung transplantation for cystic fibrosis in Sweden. Eur J Cardiothorac Surg. 2017. PMID: 28364441. doi:10.1093/ejcts/ezw328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。